LAURA HORNE: Open Payments
NPI 1104565670 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,842 in 52 payments from 25 companies in 2025. Trend: 2023 $178 · 2024 $626 · 2025 $1,842
Food & beverage: $1,241Consulting: $490Education: $111
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 3 | $546 |
| Novartis Pharmaceuticals Corporation | 5 | $133 |
| E.R. Squibb & Sons, L.L.C. | 2 | $124 |
| Janssen Biotech, Inc. | 5 | $117 |
| GENZYME CORPORATION | 3 | $99 |
| SEAGEN INC. | 1 | $95 |
| Daiichi Sankyo Inc. | 4 | $89 |
| Genentech USA, Inc. | 3 | $69 |
| Incyte Corporation | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $56 |
Products named: Lenvima, BREYANZI, SARCLISA, ENHERTU, Tecentriq, RYBREVANT, SCEMBLIX, KEYTRUDA.
Industry payments across GA — which companies pay providers there.
